Previous 10 | Next 10 |
2024-02-15 16:13:04 ET More on 10x Genomics Stocks To Watch: Eyes On Chipmakers, Tesla, Netflix And BrightSpring IPO 10x Genomics: Still Waiting For Entry 10x Genomics: Sales Are Growing At A Rapid Rate, But So Are Expenses 10x Genomics Q4 2023 Earnings Previ...
10x Genomics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Outlook for 2024 PR Newswire Q4 2023 revenue growth of 18% and FY 2023 revenue growth of 20% over the corresponding periods of 2022 PLEASANTON, Calif. , Feb. 15, 2024 /P...
2024-02-14 17:35:58 ET Major earnings expected after the bell on Thursday include: Roku ( ROKU ) Coinbase Global ( COIN ) Applied Materials ( AMAT ) The Trade Desk ( TTD ) DraftKings ( DKNG ) Read the full article on Seeking Alpha For ...
2024-02-14 15:41:42 ET More on CRISPR, Intellia Therapeutics, etc. Intellia's Bet On In-Vivo Breakthroughs: A Perspective On CRISPR's Next Frontier Crispr Therapeutics: Investors Bet Against Casgevy Uptake Biotech And Pharma Diversification Pays Off Vertex, C...
2024-02-09 13:18:13 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Life science applications specialist NanoString (NASDAQ: NSTG ), which provides tools for discovery and translation research, announced that it has entered into a credit agreement w...
2024-02-08 13:08:31 ET More on NanoString Biggest stock movers today: Nvidia, Air Products and Chemicals, Estee Lauder, 4D Molecular Therapeutics, and more NanoString stock plunges after bankruptcy filing, co weighs potential sale Seeking Alpha’s Quant Rating ...
Available funding now exceeds remaining capex, with 84% of upfront expenditures committed (All amounts expressed in U.S. dollars unless otherwise stated) Toronto, Ontario--(Newsfile Corp. - February 7, 2024) - Torex Gold Resources Inc. (the "Company" or "Torex") (TSX: TXG) provides Q4 20...
10x Genomics Expands Leadership in Single Cell Analysis with Launch of GEM-X Technology PR Newswire GEM-X, the next generation of the company's leading single cell technology architecture, enables higher performance at larger scale and lower cost Pre-orders now open fo...
10x Genomics to Showcase New Cutting-Edge Technologies and Highlight Innovation Roadmap at 2024 AGBT General Meeting PR Newswire New single cell and spatial products set to deliver higher performance, improve ease of use and enable researchers to measure more biology ...
10x Genomics to Report Fourth Quarter and Full Year 2023 Financial Results on February 15, 2024 PR Newswire PLEASANTON, Calif. , Jan. 24, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced ...
News, Short Squeeze, Breakout and More Instantly...
2024-07-23 06:00:09 ET Kyle Mikson from Canaccord Genuity issued a price target of $32.00 for TXG on 2024-07-23 05:09:00. The adjusted price target was set to $32.00. At the time of the announcement, TXG was trading at $18.11. The overall price target consensus is at $24...
10x Genomics to Report Second Quarter 2024 Financial Results on August 8, 2024 PR Newswire PLEASANTON, Calif. , July 12, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced that it will report fi...
A look at the top 10 most actives in the United States Kazia Therapeutics Limited (KZIA) rose 248.0% to $0.6682 on volume of 430,252,408 shares Maxeon Solar Technologies Ltd. (MAXN) fell 15.0% to $0.2108 on volume of 237,403,092 shares NVIDIA Corporation (NVDA) rose 2.7% to $134.91 on vol...